CD34+ Stem Cell Infusion to Augment Graft Function
Stopped CliniMACS CD34 Reagent System was FDA approved for clinical use; therefore, patients were treated clinically.
Conditions
- Waning Donor Chimerism
- Waning Immune Function
- Primary Immunodeficiency Disease(s)
- Bone Marrow Failure
Interventions
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators